A major component of the anti-carcinogenic activity of the dietary chemopreventive agent sulforaphane (SFN) is attributed to its ability to induce expression of phase II detoxification genes containing the antioxidant response element (ARE) within their promoters.
Introduction
The isothiocyanates (ITC's), such as sulforaphane (SFN), are important dietary cancer chemopreventive agents found abundantly in cruciferous vegetables [1, 2] . Epidemiological and animal data reveal an inverse correlation between consumption of dietary chemopreventive agents, such as ITC's, and the risk of developing cancer [2] [3] [4] . While there is evidence that ITC's may have direct anti-cancer activities through inhibition of cell growth and stimulation of apoptosis in susceptible cancer cells [5] [6] [7] , an extensive literature suggests that a major component of the chemopreventive activity of ITC's occurs via induction of genes encoding phase II detoxification enzymes [8] [9] [10] --a diverse family of enzymes that can metabolize a variety of reactive carcinogens, mutagens, and other toxins [11] . The phase II genes that are induced contain antioxidant (or electrophile) response elements (ARE or EpRE) in their promoters and include genes encoding NAD(P)H:quinone oxidoreductase (NQO1), glutathione S-transferases (GST), UDP-glucuronosyl transferase, epoxide hydrolase, ferritin, γ-glutamatecysteine ligase, and catalase, [11] . The ITC's can enhance phase II gene expression by increasing the levels and activation of the NF-E2-related factor 2 (Nrf2) transcription factor. Nuclear Nrf2 can heterodimerize with partner transcription factors, bind ARE's, and thereby activate transcription of target phase II genes [12] [13] [14] . Under basal conditions, Nrf2 interacts with the Kelch ECH-associating protein 1 (Keap1) [13] . Recent evidence indicates that Keap1 controls the stability of Nrf2 protein [15] --serving as an adaptor protein which links Nrf2 to E3 ubiquintin ligase thus targeting Nrf2 for proteosomal degradation [9, 16] . It is widely believed that electrophiles such as ITC's disrupt Nrf2/Keap1 interactions by reacting with key free thiols within the cysteine-rich Keap1 proteins [17] [18] [19] . Nrf2 so freed from Keap1 and proteosomal degradation is stabilized, accumulates, and is translocated to the nucleus where it can enhance phase II gene transcription. In addition, AREcontaining gene expression can be regulated by activation of MAPK pathways, direct phosphorylation of Nrf2 by PKC or PERK, or by the actions of other transcription factors and transcription factor modulators [20] [21] [22] [23] [24] .
The goal of this study is to understand some of the cellular factors that may differentially govern the chemopreventive response to ITC exposure of various cells and tissues. In particular, we examined the role of glutathione (GSH)-dependent metabolism and efflux of the ITC, SFN, in modulating SFN bioactivity--especially, its ability to induce ARE-dependent gene expression.
Prior studies have shown that ITC's readily undergo reversible Michael addition reactions with cellular nucleophiles including protein thiols and GSH. The reaction with GSH occurs both enzymatically (GST-catalysed) and non-enzymatically at physiological pH [25, 26] . Additionally, there is evidence that ITC's and/or their GSH conjugates, dithiocarbamates, are transported from cells and the role of MRP family proteins is implicated in this transport [27, 28] . Here we examine the influence of GSTP1-1 and the GSH-conjugate efflux pump, MRP1, on cellular response to SFN using model transgenic MCF7 cell lines expressing GSTP1-1 and MRP1 alone or in combination. Specifically, we test the hypothesis that--by affecting the dynamics of SFN conjugation and conjugate (SFN-SG) efflux--the levels of GSTP1-1 and MRP1 expressed at the time of SFN exposure will modulate the acute cellular response to SFN treatment. The studies described support the ideas that 1) MRP1 and GSTP1-1 influence ARE-dependent gene expression by a mechanism that involves altered intracellular SFN/SFN-SG accumulation, and 2) modulation of ARE-containing gene expression by MRP1/GSTP1-1 expression is ultimately mediated by changes in nuclear Nrf2 levels.
Materials and Methods
Cell lines and culture. We have previously described the construction and analysis of stably transduced derivatives of parental MCF7 cells (MCF7/WT or WT): these include transduced MCF7 cells expressing the I104, A113 allele of human GSTP1-1, GSTP1a-1a (MCF7/WTπ or WTπ); MRP1 (MCF7/MRP1 or MRP1); and GSTP1a-1a plus MRP1 (MCF7/MRP1π or MRP1π) [29, 30] [32] [33] [34] [35] : the studies showed that the expression levels of these MRP proteins are low to absent in parental MCF7/WT cells--in particular, MRP2
(protein and mRNA) is undetectable. SFN cytotoxicity experiments were accomplished using the sulforhodamine B assay as described previously [36] . In these experiments, cells were exposed to varying concentrations of D,L-sulforaphane (SFN, LKT Laboratories, St. Paul, MN)--freshly diluted in dimethylsulfoxide--for 3 hr, medium was replaced with fresh SFN-free medium, and incubations were continued 6 days.
Synthesis and MRP1-mediated transport of the GSH conjugate of SFN, SFN-SG.
Synthesis of radiolabeled SFN-SG was adapted from the method described by Kolm et al. [25] and reaction progress was monitored by the Δ absorbance at 274nm. and processed for intracellular SFN plus SFN-SG levels by the cyclocondensation reaction developed by Zhang et al. [38] . Briefly, lysates were transferred to microfuge tubes, centrifuged at 12,000xg for 5 min at 25 o C, and the supernatants saved for the determination of protein [39] and for SFN/SFN-SG levels. SFN/SFN-SG levels were determined by their quantitative reaction with 1,2-benzenedithiol to generate the chromophore, 1,3-benzodithiole-2-thione (BTT), as outlined [38] . The BTT was separated by reverse phase HPLC (C18, Beckman, Ultrasphere ODS, 5 μm, 4.6x250 mm) using an isocratic 80% methanol elution at 1.3 ml/min.
Chromatograms were monitored at 365 nm with BTT peaks eluting at ~6 min. SFN/SFN-SG levels were calculated for unknown samples by comparing the integrated BTT peak areas of unknown samples with integrated peak areas of BTT derived from cyclocondensation reactions with known quantities of phenyl isothiocyanate standards. Intracellular GSH levels were determined in control and SFN-treated cells using the method described by Tietze [40] . Cells (3x10 6 /plate) were seeded on replicate 150 mm plates. Twenty-four hr later, cells were treated with 25 μM SFN for 1 hr. Cells were harvested at intervals during the 1 hr incubation for determination of total intracellular GSH. The basal GSH levels in unstressed, untreated (no SFN) cells were similar among the four cell lines used: these levels ranged from 7-12 mM and were comparable to those previously reported for MCF7 derivatives by our laboratory [41] . luminometer. Renilla luciferase activities were used to correct firefly pARE-TI-LUC reporter gene activities for variation in transfection efficiencies and non-specific induction. The pARE-TI-LUC vector was constructed with the 41 bp ARE-containing insert derived from the murine gsta1 gene linked to a TATA-Inr minimal promoter as described by Wasserman and Fahl [42] .
For analysis of endogenous ARE-dependent gene induction, 2x10 6 cells were seeded on 100 mm dishes and 24 hr later treated with medium containing 25 μM SFN or vehicle control for 3 hr. Medium was replaced with SFN-free medium and cells were harvested for total RNA preparation and Northern blot analysis as described previously [43] . The Northern blot was probed with a cDNA insert, containing the entire coding region of human NQO1, which was labeled with [α-32 P]-dCTP by random primer labeling [43] . The cDNA was derived from MCF7
cells by RT-PCR of total cellular RNA using the following oligonucleotides: 5'-CAC GAG CCC AGC CAA TCA-3' and 5'-CCA GGA TAA GGA ATC TCA-3'. The ARE located within the human NQO1 ARE contains an embedded AP-1 site whereas the murine gsta1 ARE, found in the pARE-TI-LUC reporter, does not [44] .
Analysis of cytoplasmic and nuclear Nrf2. Cells were plated at a density of 2x10 6 per 100 mm dish. Twenty-four hr later, cells were treated for 3 hr in medium containing 25 μM SFN or vehicle control. After the 3 hr exposure, medium was replaced with SFN-free medium and incubations continued for 2-18 hr before harvesting. Cells were rinsed and pelleted in PBS. Cell pellets were suspended in ~3 volumes ice cold hypotonic buffer (20 mM KHEPES (pH 7.9), 10 mM KCl, 1 mM EDTA, 10% glycerol, 1 mM DTT, 0.2% NP40, 1 mM PMSF, 50 μg/ml aprotin, 0.5 μg/ml leupeptin, and 1 μg/ml pepstatin). Hypotonic buffer was added slowly with continuous gentle vortexing which was continued 10 s after the addition of buffer. This lysate was incubated on ice 5 min and was then pelleted by microcentrifugation at full speed for 10 s. The cytosolic supernatant was removed and saved while the nuclear pellet was suspended in ~3 volumes ice cold extraction buffer (hypotonic buffer supplemented with glycerol and 5 M NaCl to give final concentrations of 20% and 420 mM, respectively) added slowly with continuous gentle vortexing. The sample was held on ice for 30 min with periodic gentle vortexing every 5-10 min.
The sample was centrifuged at 12,000xg, 5 min, 4 o C and the nuclear extract (supernatant) was collected. The nuclear and cytoplasmic fractions were processed for protein assay [39] and Western blotting.
Cytoplasmic and nuclear extracts (50 μg protein per sample) were separated by 8%
acrylamide SDS-PAGE and transferred to Hybond-ECL nitrocellulose membranes (Amersham Biosciences). Western analysis was accomplished using rabbit anti-Nrf2 primary antibody (H300, Santa Cruz Biotechnology), HRP-conjugated goat anti-rabbit secondary antibody, and enhanced chemiluminescence (Perkin-Elmer) using standard methods [29] . To verify similar loading and transfer efficiencies, blots were stripped and re-probed with anti-human actin (C2, Santa Cruz) or anti-human topoisomerase I (23B11, Alexis) primary antibodies and the appropriate HRP-conjugated secondary antibodies.
Results

MRP1 and GSTP1-1 influence the dynamics of SFN and SFN-SG accumulation and
efflux. Previous work has indicated that GSH conjugates of ITC's are actively transported out of cells [28] . It was expected that the GSH-conjugate efflux pump, MRP1, could support this active efflux of SFN-SG. To verify that this is true and to estimate the efficiency of efflux, the kinetics of ATP-dependent, MRP1-mediated transport of SFN-SG was measured using inside-out plasma GSTP1-1 can catalyze SFN conjugation with GSH and may, therefore, significantly alter the rate of intracellular GSH consumption in cells treated with SFN. Since changes in intracellular GSH can influence sensitivity to redox/electrophile stress (including stress due to SFN exposure), we investigated whether the increased rate of SFN-SG formation in GSTP1-1 expressing cells would be associated with measurable differences in the rates of GSH depletion.
As shown in Figure 2B , GSTP1-1 expression ± MRP1 (WTπ and MRP1π cells) resulted in higher initial rates of GSH depletion than in cells that lacked GSTP1-1 (WT and MRP1).
Although expression of GSTP1-1 alone (WTπ) was associated with increased initial rates of GSH depletion, the extent of GSH depletion at later times was similar to GSTP1-1-minus cells (WT and MRP1). In contrast, co-expression of MRP1 with GSTP1-1 (MRP1π) resulted in marked increases in both the rate and extent of GSH depletion.
Consequences on SFN bioactivities of altered SFN/SFN-SG and GSH dynamics mediated
by MRP1 and GSTP1-1 expression. At higher exposure levels, ITC's are known cellular toxins.
To determine whether the altered SFN and GSH metabolism associated with MRP1 and GSTP1-1 expression would affect sensitivity to SFN cytotoxicity, the four cell lines were exposed to varying concentration of SFN for 3 hr. Very little toxicity was observed in any of the cell lines at SFN concentrations ≤ 25 μM SFN (Figure 3) . Moreover, despite significant differences in SFN and GSH metabolism, there were no consistent differences in sensitivity to SFN cytotoxicity at higher exposure levels among the four cell lines. Additionally, no differences in relative sensitivities to SFN cytotoxicity were observed among the four cell lines even when the duration of SFN exposure was varied between 1 and 24 hr (not shown).
We oxidized to a quinone within the cell and, as shown by Nakamura et al. [46] , the quinone has the potential to form GSH conjugates, two considerations suggest that GSH conjugation is not a major pathway for tBHQ disposition in the cell: 1) The quinone can be reduced back to the hydroquinone by cellular reductases limiting that amount of substrate vulnerable to Michael addition with GSH. 2) In the Nakamura paper, the rate of tBHQ-SG formation was extremely slow and the extent of conjugation was very low. Indeed, in cells exposed to 10μM tBHQ for several hr, tBHQ-SG accumulated to concentrations of only 2-3 nM. In contrast, treatment of MCF7/WT cells with 25 μM SFN resulted in accumulation of SFN-SG to levels exceeding 1 mM within 5 min ( Fig. 2A ) (estimation based upon total intracellular protein concentration ~150 mg/ml).
As shown in Figure 5A , there were no significant differences in tBHQ-mediated induction of ARE-reporter gene activity among the four cell lines. To further investigate the importance of SFN/GSH conjugation in the modulation by MRP1 and GSTP1-1 of SFNmediated induction, experiments were conducted in which GSH was depleted by 24 h exposure to 50 μM BSO prior to SFN treatment. Such BSO treatment results in ≥ 90 % reduction of intracellular GSH [33] . Following GSH depletion, SFN-mediated ARE-reporter gene activation was similar among the four cell lines ( Figure 5B ). In aggregate, these results indicate that the modulatory effects of MRP1 and GSTP1-1 expression on SFN bioactivity are indeed GSH dependent.
MRP1 expression attenuates SFN-mediated increases in Nrf2 levels. The transcription
factor, Nrf2, binds as a heterodimer to the ARE motifs and is thereby a principle mediator of ARE-containing promoter activation [12] . To gain insights into the mechanism(s) by which A variety of transcription factors, regulatory proteins and signaling pathways have been implicated in the regulation of ARE-dependent, phase II gene transcription [8, [21] [22] [23] 48, 49] . The best studied is Nrf2, a transcription factor that in combination with its partner(s) forms a heterodimer which binds to the ARE motif and activates transcription. Under basal conditions, in most cells Nrf2 is negatively regulated by Keap1, a cysteine-rich cytosolic protein with which Nrf2 interacts. It has been found that thiol-reactive electrophiles, such as ITC's, interact with key cysteine residues on Keap1 either via adduct formation and/or inducing intra-or intermolecular disulfide bond formation [17, 19] . Such ITC-dependent reactions are believed to disrupt Keap1-Nrf2 interactions. Initially it was believed that this simply resulted in the release of Nrf2 sequestered in the cytosol allowing its translocation to the nucleus where target genes are activated [13] . Recent findings suggest a more active role for Keap1 in the repression of Nrf2:
Keap1 serves as an adaptor protein that links Nrf2 to Cul3-based E3 ubiquitin ligase thus targeting Nrf2 for proteosomal degradation [16] . Figure 6A ). The high rate with which this increase occurs is compatible with a mechanism that involves stabilization of a Nrf2 protein whose synthesis is constitutive and rapid--although we cannot rule out the possible contribution of increased synthesis as suggested in some models [50] . At later times--beyond 2 hr following SFN treatment--the effects of MRP1 and GSTP1-1 on increased Nrf2 expression become apparent with consistently lower levels of Nrf2 persisting in the cytosolic and nuclear fractions of MRP1-rich (MCF7/MRP1 and MCF7/MRP1π) than in MRP1-poor (MCF7/WT and MCF7/π) cells ( Figure 6 ).
In aggregate, our results indicate that, by regulating intracellular levels of SFN/SFN-SG after SFN treatment, MRP1 and GSTP1-1 modulate ARE-dependent gene expression via altering indirectly modulate ARE-containing gene expression [24, 51] or apoptosis [7] . In addition, direct phosphorylation of Nrf2 by PKC and PERK have been implicated in Nrf2 activation [21, 52] .
Such considerations of redox or electrophilic stress are certainly germane to our model system.
Indeed we find that co-expression of GST and MRP1 significantly increases the rate and extent of intracellular GSH depletion ( Figure 2B ). This is not unexpected in view of the catalytic and conjugate transport roles of GST and MRP1 which together can greatly enhance the net flux of GSH (as conjugate) from cells exposed to high levels of electrophiles. It is not unreasonable to suggest, then, that the extreme GSH depletion associated with SFN treatment of cells expressing both MRP1 and GSTP1 (MCF7/MRP1π) would render these cells particularly vulnerable to further redox stress caused by SFN as well as endogenous pro-oxidants. Based upon the literature of redox signaling, if variable GSH depletion was an important component of the differential response to SFN observed in our model cell lines, then the increased redox stress in MCF7/MRP1π cells might result in enhanced activation of ERK/JNK signaling pathways which are reported to enhance ARE-dependent transactivation [51] . In addition, or alternatively, the increased redox signaling could be manifest as enhanced apoptosis [6, 7] . nearly undetectable in liver but present at particularly high levels in lung, testis, kidney, skeletal muscle and heart [53] . Moreover, MRP1 is differentially expressed within various cell types of particular tissues. The tissue distributions of the alternative GSH-conjugate efflux pumps, MRP2-4, are even more restricted than MRP1 [54, 55] . The cytosolic isozymes of GST known to catalyze ITC conjugation also have unique tissue distribution and expression level patterns [56, 57] . For example, GSTP1-1, while widely expressed but at variable levels in many tissues and tumors, is absent in others such as adult liver. The ITC-inducible GST's of the alpha class are expressed at high levels in liver but differentially and at lower basal levels in other tissues including kidney, adrenal gland and the gut. It is likely that the variable MRP/GST phenotypes observed among different tissues and cell types could have a significant influence on the magnitude and efficacy of the chemopreventive response to SFN or other ITC exposure.
It should also be noted that ITC's can induce enzymes that influence their own metabolism including alpha class GST(s) [58] and, in the mouse at least, Mrp family proteins [59, 60] . In MCF7/WT cells, GSTA1/2 expression, while undetectable at the protein level, is apparent, in very low copy number, at the RNA level (~20-50 copies per μg RNA, Q-RT-PCR, unpublished). Indeed, GSTA1/2 RNA was induced 2-6 fold in MCF7/WT cells treated with 25
μM SFN but the protein remained undetectable and GST activity was unchanged (< 5 nmol•min 
